Protein Description

Gene Symbol VDR
Entrez ID 7421
Uniprot ID P11473
Description vitamin D (1,25- dihydroxyvitamin D3) receptor
Chromosomal Location chr12: 47,841,537-47,943,048
Ontology GO ID GO Term Definition Evidence

BP

GO:0000122

negative regulation of transcription from RNA polymerase II promoter

Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IDA

BP

GO:0000902

cell morphogenesis

The developmental process in which the size or shape of a cell is generated and organized.

IMP

BP

GO:0001501

skeletal system development

The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).

IEA

BP

GO:0006367

transcription initiation from RNA polymerase II promoter

Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.

TAS

BP

GO:0006816

calcium ion transport

The directed movement of calcium (Ca) ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

IEA

BP

GO:0006874

cellular calcium ion homeostasis

Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell.

IEA

BP

GO:0007165

signal transduction

The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

TAS

BP

GO:0007595

lactation

The secretion of milk by the mammary gland.

IEA

BP

GO:0008285

negative regulation of cell proliferation

Any process that stops, prevents or reduces the rate or extent of cell proliferation.

IDA

BP

GO:0010628

positive regulation of gene expression

Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.

IMP

BP

GO:0010839

negative regulation of keratinocyte proliferation

Any process that decreases the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population.

IMP

BP

GO:0010980

positive regulation of vitamin D 24-hydroxylase activity

Any process that increases the rate, frequency or extent of vitamin D 24-hydroxylase activity. Vitamin D 24-hydroxylase activity catalyzes the hydroxylation of C-24 of any form of vitamin D.

IDA

BP

GO:0038183

bile acid signaling pathway

A series of molecular signals initiated by the binding of a bile acid to a receptor, and ending with regulation of a downstream cellular process, e.g. transcription.

IDA

BP

GO:0043401

steroid hormone mediated signaling pathway

A series of molecular signals mediated by a steroid hormone binding to a receptor.

IEA

BP

GO:0045618

positive regulation of keratinocyte differentiation

Any process that activates or increases the frequency, rate or extent of keratinocyte differentiation.

IMP

BP

GO:0045892

negative regulation of transcription, DNA-templated

Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.

IDA

BP

GO:0045944

positive regulation of transcription from RNA polymerase II promoter

Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IMP

BP

GO:0046697

decidualization

The cellular and vascular changes occurring in the endometrium of the pregnant uterus just after the onset of blastocyst implantation. This process involves the proliferation and differentiation of the fibroblast-like endometrial stromal cells into large, polyploid decidual cells that eventually form the maternal component of the placenta.

IEP

BP

GO:0050892

intestinal absorption

Any process in which nutrients are taken up from the contents of the intestine.

IEA

BP

GO:0060058

positive regulation of apoptotic process involved in mammary gland involution

Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process of mammary epithelial cells during mammary gland involution.

IEA

BP

GO:0060558

regulation of calcidiol 1-monooxygenase activity

Any process that modulates the rate, frequency or extent of calcidiol 1-monooxygenase activity. Calcidiol 1-monooxygenase activity is catalysis of the reaction: calcidiol + NADPH + H+ + O2 = calcitriol + NADP+ + H2O.

ISS

BP

GO:0060745

mammary gland branching involved in pregnancy

The process in which the branching structure of the mammary gland duct is generated and organized as a part of pregnancy.

IEA

BP

GO:0070561

vitamin D receptor signaling pathway

The series of molecular signals generated as a consequence of a vitamin D receptor binding to one of its physiological ligands.

IDA

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

IDA

CC

GO:0005654

nucleoplasm

That part of the nuclear content other than the chromosomes or the nucleolus.

IDA|TAS

CC

GO:0043235

receptor complex

Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

IDA

CC

GO:0090575

RNA polymerase II transcription factor complex

A transcription factor complex that acts at promoters of genes transcribed by RNA polymerase II.

IDA

MF

GO:0003677

DNA binding

Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

IDA

MF

GO:0003700

transcription factor activity, sequence-specific DNA binding

Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.

IDA

MF

GO:0003707

steroid hormone receptor activity

Combining with a steroid hormone and transmitting the signal within the cell to initiate a change in cell activity or function.

IEA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0008270

zinc ion binding

Interacting selectively and non-covalently with zinc (Zn) ions.

IEA

MF

GO:0008434

calcitriol receptor activity

Combining with calcitriol, the hormonally active form of vitamin D3, and transmitting the signal to the transcriptional machinery by interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II.

IDA

MF

GO:0038186

lithocholic acid receptor activity

Combining with lithocholic acid and transmitting the signal to initiate a change in cell activity.

IDA

MF

GO:0043565

sequence-specific DNA binding

Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.

IEA

MF

GO:0046965

retinoid X receptor binding

Interacting selectively and non-covalently with a retinoid X receptor.

IPI

MF

GO:0070644

vitamin D response element binding

Interacting selectively and non-covalently with the vitamin D response element (VDRE), a short sequence with dyad symmetry found in the promoters of some of the cellular immediate-early genes, regulated by serum.

IDA

MF

GO:1902098

calcitriol binding

Interacting selectively and non-covalently with calcitriol. Calcitriol (1,25-dihydroxycholecalciferol) is the hormonally active form of vitamin D3.

IDA

MF

GO:1902121

lithocholic acid binding

Interacting selectively and non-covalently with lithocholic acid.

IDA

Domain ID Description

IPR000324

Vitamin D receptor

IPR000536

Nuclear hormone receptor, ligand-binding domain

IPR001628

Zinc finger, nuclear hormone receptor-type

IPR001723

Nuclear hormone receptor

IPR013088

Zinc finger, NHR/GATA-type

Pathway ID Pathway Term Pathway Source

hsa04961

Endocrine and other factor-regulated calcium reabsorption

KEGG

hsa04978

Mineral absorption

KEGG

hsa05152

Tuberculosis

KEGG

WP1531

Vitamin D Metabolism

WikiPathways

WP34

Ovarian Infertility Genes

WikiPathways

WP299

Nuclear Receptors in Lipid Metabolism and Toxicity

WikiPathways

WP170

Nuclear Receptors

WikiPathways

WP2289

Drug Induction of Bile Acid Pathway

WikiPathways

h_vdrPathway

Control of Gene Expression by Vitamin D Receptor

BioCarta

h_nuclearRsPathway

Nuclear Receptors in Lipid Metabolism and Toxicity

BioCarta

UMLS CUI UMLS Term

C0002170

Alopecia

C0007138

Carcinoma, Transitional Cell

C0014556

Epilepsy, Temporal Lobe

C0020538

Hypertensive Disease

C0023176

Lead Poisoning

C0023434

Chronic Lymphocytic Leukemia

C0029456

Osteoporosis

C0033578

Prostatic Neoplasms

C0035579

Rickets

C0041948

Uremia

C0042870

Vitamin D Deficiency

C1458155

Mammary Neoplasms

No tissues found.

Database Name

DisGeNET

DGA

Pubmed ID Author Year Title

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

Gene Symbol Entrez ID Uniprot ID Score

PPP1CA

5499

P62136

0.52

NR2E3

10002

Q9Y5X4

0.52

POLR2A

5430

P24928

0.62

BRCA1

672

P38398

0.63

CDK11B

984

P21127

0.63

CDKN1A

1026

P38936

0.63

EGR1

1958

P18146

0.63

FGR

2268

P09769

0.63

HDAC2

3066

Q92769

0.63

HNF4A

3172

P41235

0.63

MDM2

4193

Q00987

0.63

FOXO4

4303

P98177

0.63

NR1H2

7376

P55055

0.63

NRIP1

8204

P48552

0.63

NR0B2

8431

Q15466

0.63

GNPAT

8443

O15228

0.63

EIF3I

8668

Q13347

0.63

HMGN3

9324

Q15651

0.63

MED23

9439

Q9ULK4

0.63

MED7

9443

O43513

0.63

CLASRP

11129

Q8N2M8

0.63

GABARAPL2

11345

P60520

0.63

GABARAPL1

23710

Q9H0R8

0.63

SIN3A

25942

Q96ST3

0.63

MED4

29079

Q9NPJ6

0.63

MMRN2

79812

Q9H8L6

0.63

CASC4

113201

Q6P4E1

0.63

CDK7

1022

P50613

0.65

GTF2B

2959

Q00403

0.65

ACTN4

81

O43707

0.68

FOXO3

2309

O43524

0.68

SIRT1

23411

Q96EB6

0.68

TAF11

6882

Q15544

0.72

TRRAP

8295

Q9Y4A5

0.72

MED21

9412

Q13503

0.72

THRAP3

9967

Q9Y2W1

0.72

BAG1

573

Q99933

0.73

RXRB

6257

P28702

0.73

RXRG

6258

P48443

0.73

FOS

2353

P01100

0.75

JUN

3725

P05412

0.75

TDG

6996

Q13569

0.75

TP53

7157

P04637

0.75

RUNX1

861

Q01196

0.78

RUNX1T1

862

Q06455

0.78

STAT1

6772

P42224

0.79

SMAD3

4088

P84022

0.81

TCF3

6929

P15923

0.81

HR

55806

O43593

0.81

SMARCA4

6597

P51532

0.82

MED13

9969

Q9UHV7

0.82

MED6

10001

O75586

0.82

MED16

10025

Q9Y2X0

0.82

MED24

9862

O75448

0.83

PPP1CC

5501

P36873

0.84

MED14

9282

O60244

0.84

MED12

9968

Q93074

0.85

SRC

6714

P12931

0.86

BAZ1B

9031

Q9UIG0

0.88

RXRA

6256

P19793

0.90

VDR

7421

P11473

0.96

CSNK2A1

1457

P68400

0.52

PPP2CA

5515

P67775

0.52

MAPK1

5594

P28482

0.52

MAPK3

5595

P27361

0.52

GRIP1

23426

Q9Y3R0

0.56

LCOR

84458

Q96JN0

0.56

TRIM24

8805

O15164

0.59

CEBPA

1050

P49715

0.63

CFH

3075

P08603

0.63

MXD1

4084

Q05195

0.63

MYC

4609

P01106

0.63

PRCP

5547

P42785

0.63

PRKCSH

5589

P14314

0.63

TAF7

6879

Q15545

0.63

RNF14

9604

Q9UBS8

0.63

CXXC5

51523

Q7LFL8

0.63

CDCA7L

55536

Q96GN5

0.63

NSD1

64324

Q96L73

0.63

NKD2

85409

Q969F2

0.63

ACVR1

90

Q04771

0.65

PPARG

5468

P37231

0.68

NCOA4

8031

Q13772

0.68

COPS2

9318

P61201

0.68

NCOA6

23054

Q14686

0.68

SRPK1

6732

Q96SB4

0.70

CREBBP

1387

Q92793

0.73

POU1F1

5449

P28069

0.75

POU2F1

5451

P14859

0.75

PTPN3

5774

P26045

0.75

RB1

5925

P06400

0.75

KDM5A

5927

P29375

0.75

PSMC5

5705

P62195

0.76

CCND3

896

P30281

0.77

NCOA1

8648

Q15788

0.82

EP300

2033

Q09472

0.84

NCOR2

9612

Q9Y618

0.87

ZBTB16

7704

Q05516

0.89

NCOA3

8202

Q9Y6Q9

0.89

NCOR1

9611

O75376

0.89

MED1

5469

Q15648

0.90

NCOA2

10499

Q15596

0.90

SNW1

22938

Q13573

0.90